Skip to content

Insider · CIK 0001563565

Carruthers Wendy

officer

Files at BSX (BOSTON SCIENTIFIC CORP). First filing Nov 4, 2024, latest Dec 4, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.2M sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
20Weaksell 510b5-1BSX
BOSTON SCIENTIFIC CORP
$634k6,983-19%-
19Weaksell 310b5-1BSX
BOSTON SCIENTIFIC CORP
$589k6,983-18%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 2, 2024BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock10b5-1
+3,066$17.26$53k35,094Dec 4, 2024
Dec 2, 2024BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock10b5-1
+1,197$24.55$29k36,291Dec 4, 2024
Dec 2, 2024BSX
BOSTON SCIENTIFIC CORP
SOpen-market sale
Common Stock10b5-1
-6,983$90.78$634k29,308Dec 4, 2024
Dec 2, 2024BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-3,066$0.00$00Dec 4, 2024
Dec 2, 2024BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-1,197$0.00$013,183Dec 4, 2024
Nov 1, 2024BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock10b5-1
+3,066$17.26$53k37,814Nov 4, 2024
Nov 1, 2024BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock10b5-1
+1,197$24.55$29k39,011Nov 4, 2024
Nov 1, 2024BSX
BOSTON SCIENTIFIC CORP
SOpen-market sale
Common Stock10b5-1
-6,983$84.33$589k32,028Nov 4, 2024
Nov 1, 2024BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-3,066$0.00$03,066Nov 4, 2024
Nov 1, 2024BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-1,197$0.00$014,380Nov 4, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Carruthers Wendy: insider trades and track record | InsiderTell